SCHEMBL3132965

SCHEMBL3132965

CC(OS(C)(=O)=O)C1CCN(C(=O)O)CC1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
CPN1 P15169 3/20 0.33
CPB2 Q96IY4 3/20 0.33
TP53 P04637 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
MMP1 P03956 4/20 0.32
MMP13 P45452 4/20 0.32
MMP3 P08254 3/20 0.32
MMP7 P09237 3/20 0.32
MMP9 P14780 3/20 0.32
MMP8 P22894 3/20 0.32
HTT P42858 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
MAPT P10636 1/20 0.31
MMP2 P08253 2/20 0.31
GPR119 Q8TDV5 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25291471 0.92 ALDH1A1 (0.35) ALDH1A1CPN1CPB2TP53TDP1
SCHEMBL2369963 0.92 ALDH1A1 (0.35) ALDH1A1CPN1CPB2TP53TDP1
SCHEMBL25291469 0.92 ALDH1A1 (0.35) ALDH1A1CPN1CPB2TP53TDP1
SCHEMBL25291470 0.92 ALDH1A1 (0.35) ALDH1A1CPN1CPB2TP53TDP1
SCHEMBL2369968 0.92 ALDH1A1 (0.35) ALDH1A1CPN1CPB2TP53TDP1
SCHEMBL384998 0.83 GPR119 (0.44) MMP1MMP13MMP3MMP7MMP9
SCHEMBL866117 0.83 GPR119 (0.44) MMP1MMP13MMP3MMP7MMP9
SCHEMBL25278800 0.82 CYP2C19 (0.37) ALDH1A1GPR119
SCHEMBL470524 0.80 GPR119 (0.48) ALDH1A1MMP1MMP13MMP3MMP7
SCHEMBL24092369 0.80 GPR119 (0.48) ALDH1A1MMP1MMP13MMP3MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3331869-A1 MUSCARINIC AGONISTS Heptares Therapeutics Limited (GB) 2018-06-13 EP disclosed
WO-2017021730-A1 MUSCARINIC AGONISTS HEPTARES THERAPEUTICS LIMITED (GB) 2017-02-09 WO disclosed
CN-102348703-A Compounds for the treatment of metabolic disorders PROSIDION LTD 2012-02-08 CN disclosed
EP-2205083-A1 SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS Merck Sharp & Dohme Corp. (US) 2010-07-14 EP disclosed
WO-2009045382-A1 SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS MERCK & CO., INC. (US) 2009-04-09 WO disclosed